What labs and imaging studies should be ordered in primary care for a 39‑year‑old woman with a 10‑year history of infertility and no prior fertility evaluation?

Initial Infertility Workup for a 39-Year-Old Woman

For a 39-year-old woman with 10 years of infertility and no prior evaluation, order thyroid-stimulating hormone (TSH), prolactin, day-3 follicle-stimulating hormone (FSH) and luteinizing hormone (LH), mid-luteal progesterone, and transvaginal pelvic ultrasound; simultaneously obtain semen analysis from her partner and refer promptly to a reproductive endocrinology specialist given her advanced maternal age and prolonged infertility duration. 1, 2

Critical Context for This Patient

• At age 39, this patient requires immediate evaluation and treatment rather than waiting any additional time, as female age is the strongest predictor of fertility success and ovarian reserve declines rapidly after age 35. 1, 2, 3
• The 10-year duration of infertility is highly concerning and suggests either severe pathology or that conception attempts have been suboptimal; this warrants both comprehensive workup and urgent subspecialty referral. 1, 2

Essential Laboratory Tests

Hormonal Assessment

• TSH (thyroid-stimulating hormone): Order when clinical features suggest thyroid disease or as part of comprehensive infertility workup, as thyroid disorders impair ovulation and pregnancy outcomes. 1
• Serum prolactin (morning, resting level): Measure to exclude hyperprolactinemia, particularly if the patient has galactorrhea, irregular cycles, or hirsutism; levels >20 μg/L are abnormal. 1
• Day-3 FSH and LH: Draw between cycle days 3-6 to assess ovarian reserve; FSH >35 IU/L indicates diminished reserve, and LH/FSH ratio >2 suggests polycystic ovary syndrome (PCOS). 1, 4, 5
• Mid-luteal progesterone (cycle day 21 in a 28-day cycle): Levels <6 nmol/L indicate anovulation, commonly caused by PCOS, hypothalamic amenorrhea, or hyperprolactinemia. 1, 5

Additional Labs When Indicated

• Testosterone and androstenedione: Order if signs of androgen excess (hirsutism, acne, male-pattern hair loss) are present; testosterone >2.5 nmol/L suggests PCOS or adrenal pathology. 1
• Fasting glucose and insulin: Obtain if obesity or PCOS is suspected, as insulin resistance is common; fasting glucose >7.8 mmol/L or glucose/insulin ratio >4 indicates metabolic dysfunction. 1
• Complete blood count, urinalysis, blood type and screen: Part of preconception care to optimize maternal health. 1
• Infectious disease screening (rubella, syphilis, hepatitis B, HIV, gonorrhea, chlamydia): Recommended for preconception health and required before assisted reproduction. 1, 6

Essential Imaging Studies

Transvaginal Pelvic Ultrasound (First-Line)

• Transvaginal ultrasound is the initial imaging modality to assess ovarian reserve by antral follicle count, evaluate for polycystic ovarian morphology (>25 follicles 2-8 mm or ovarian volume >10 mL), detect uterine abnormalities (fibroids, polyps, congenital anomalies), and identify adnexal masses or endometriomas. 1, 2, 4
• Perform between cycle days 3-9 for optimal follicle visualization. 1

Hysterosalpingography (HSG) or Sonohysterography

• Hysterosalpingography evaluates tubal patency and uterine cavity contour; it is indicated in this patient given the prolonged infertility duration and to rule out tubal obstruction from prior pelvic inflammatory disease or endometriosis. 1, 4, 5
• Defer HSG if the patient has active pelvic infection, recent sexually transmitted infection, or known hydrosalpinx; in such cases, proceed directly to laparoscopy. 5
• Sonohysterography (saline-infusion ultrasound) can assess the uterine cavity for polyps, fibroids, or synechiae but does not evaluate tubal patency. 1

Advanced Imaging (When Indicated)

• MRI pelvis is reserved for cases where ultrasound findings are equivocal or to characterize deep infiltrating endometriosis, adenomyosis, or complex uterine anomalies. 1
• Laparoscopy with chromopertubation remains the gold standard for diagnosing and staging endometriosis and for evaluating tubal patency when HSG is contraindicated or abnormal. 1, 4

Male Partner Evaluation (Mandatory)

• Semen analysis (two samples, one month apart) is essential because male factor contributes to 40-50% of infertility cases; evaluate volume, concentration, total motile sperm count (TMSC), progressive motility, and morphology. 1, 2, 6, 3
• If TMSC <10 million, assisted reproductive technology will be required. 2, 6
• Obtain reproductive history (prior pregnancies, testicular trauma, infections, surgeries, medications including anabolic steroids) and perform genital-focused physical examination. 1, 6

Focused History and Physical Examination

History Elements to Document

• Duration and frequency of unprotected intercourse: Confirm they are having intercourse every 1-2 days after menstruation ends, as suboptimal timing is a common correctable factor. 1, 2
• Menstrual history: Cycle length, regularity, and characteristics; cycles <23 days (polymenorrhea) or >35 days (oligomenorrhea) suggest ovulatory dysfunction. 1
• Prior pregnancies, miscarriages, or ectopic pregnancies with current or previous partners. 1, 2
• History of pelvic inflammatory disease, sexually transmitted infections (especially chlamydia), endometriosis, or pelvic/abdominal surgery, as these cause tubal damage in 14% of infertility cases. 1, 2, 7
• Medical conditions: Thyroid disorders, diabetes, PCOS symptoms (irregular periods, hirsutism, acne), galactorrhea. 1
• Medications and allergies, particularly those affecting ovulation or implantation. 1
• Lifestyle factors: Smoking, alcohol (eliminate completely), recreational drugs, caffeine intake (limit to <5 cups/day), occupational exposures, and body weight. 1, 2, 6

Physical Examination Findings

• BMI calculation: <18.5 kg/m² (underweight) or >30 kg/m² (obesity) reduce fertility in both partners. 1, 2, 6
• Thyroid examination: Palpate for enlargement, nodules, or tenderness. 1, 2
• Breast examination: Check for galactorrhea by expressing nipples. 1
• Signs of hyperandrogenism: Hirsutism (Ferriman-Gallwey score), acne, male-pattern hair loss, or male escutcheon suggest PCOS. 1, 2
• Pelvic examination: Assess for uterine size/shape/mobility, adnexal masses or tenderness, cul-de-sac nodularity (endometriosis), vaginal or cervical abnormalities. 1, 2

Immediate Referral to Reproductive Endocrinology

• This patient meets criteria for urgent subspecialty referral due to age 39,10-year infertility duration, and no prior evaluation; publicly funded or private fertility specialist assessment should be arranged immediately. 2
• Referral is warranted for women >35 years after 6 months of infertility, for permanent causes requiring assisted reproductive technology, and when basic workup reveals abnormalities (anovulation, tubal obstruction, severe male factor, diminished ovarian reserve). 1, 2, 3

Lifestyle Optimization (Initiate Immediately)

• Intercourse timing: Advise every 1-2 days beginning after menstruation ends. 2, 6
• Smoking cessation for both partners (reduces fertility significantly). 2, 6
• Eliminate alcohol and recreational drugs completely. 2, 6
• Limit caffeine to <5 cups/day. 2, 6
• Avoid commercial vaginal lubricants, which impair sperm motility. 2, 6
• Folic acid 400-800 mcg daily and iodine supplementation for the female partner. 2, 6
• Vitamin D supplementation if risk factors for deficiency exist. 2
• Weight optimization: Target BMI 20-26 kg/m². 6

Critical Pitfalls to Avoid

• Do not delay subspecialty referral in a 39-year-old woman with 10 years of infertility; time is the enemy, and ovarian reserve declines precipitously at this age. 2, 3
• Do not evaluate the female partner in isolation; simultaneous male evaluation is mandatory because 40-50% of infertility involves male factors. 1, 6, 3
• Do not rely on a single semen analysis; at least two samples one month apart are required. 6
• Do not order HSG if active pelvic infection or recent STI is present; treat infection first or proceed to laparoscopy. 5
• Do not prescribe testosterone or anabolic steroids to the male partner, as they suppress spermatogenesis. 6